Zhejiang: Accelerate the deployment of new antibody drugs, medical artificial intelligence, and high-end medical devices and other frontier fields, and develop a key R&D list for innovative drugs and innovative medical devices.

MarsBitNews · 2026-04-10T05:45:56+00:00

Zhejiang Province issues guidance to support the high-quality development of the biomedical industry, focusing on cutting-edge technologies such as cell and gene therapy, new drugs, and more, promoting the research and development of innovative drugs and medical devices, and strengthening intellectual property management and basic research.

MarsBitNews

2026-04-10 05:45:56

Abstract generation in progress

Mars Finance News April 10 - Recently, the “Guiding Opinions on Promoting High-Quality Development of the Biopharmaceutical Industry in Zhejiang Province (Draft for Comments)” was publicly solicited for opinions. Among them, it mentions supporting the research and development of cutting-edge technologies and products. Guided by clinical needs, accelerate the deployment of frontier fields such as cell and gene therapy, new antibody drugs, new small molecule drugs, nucleic acid drugs, radioactive drugs, modern Chinese medicine, medical artificial intelligence, and high-end medical devices, and establish a key R&D list for innovative drugs and medical devices. Systematically implement basic applied research projects in the biopharmaceutical field and major provincial science and technology projects. Support the construction of biopharmaceutical intellectual property operation centers, deepen patent navigation analysis, and provide rapid pre-examination services for high-value patents. (Zhejiang Provincial Department of Economy and Information Technology website)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.